MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 296 filers reported holding MEDICINES CO in Q4 2019. The put-call ratio across all filers is 0.95 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q3 2018 | $3,000 | -25.0% | 102 | 0.0% | 0.00% | – |
Q2 2018 | $4,000 | – | 102 | +1940.0% | 0.00% | – |
Q1 2018 | $0 | – | 5 | 0.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 5 | -95.7% | 0.00% | – |
Q3 2017 | $4,000 | 0.0% | 115 | 0.0% | 0.00% | – |
Q2 2017 | $4,000 | -33.3% | 115 | 0.0% | 0.00% | – |
Q1 2017 | $6,000 | +50.0% | 115 | 0.0% | 0.00% | – |
Q4 2016 | $4,000 | +33.3% | 115 | +47.4% | 0.00% | – |
Q3 2016 | $3,000 | – | 78 | +1460.0% | 0.00% | – |
Q2 2016 | $0 | -100.0% | 5 | -79.2% | 0.00% | – |
Q4 2015 | $1,000 | – | 24 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |